Výsledky vyhledávání - "E G, Favalli"

OP0089 RNAseq PROFILING OF RHEUMATOID ARTHRITIS PATIENTS TO PREDICT RESPONSE TO TOFACITINIB

Autor: C. Bellocchi, G. Maioli, E. G. Favalli, E. Agape, M. Rossato, C. De Quattro, A. Severino, M. Biggioggero, E. Trombetta, B. Vigone, R. Caporali, L. Beretta

Publikováno v: Annals of the Rheumatic Diseases. 81:59-60

BackgroundRheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis and progressive disability. Nowadays the natural history and the prognosis of the disease has deeply changed thanks to the availability of conventional and targete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f01f7a2b624ba899703809c946d5519f
https://doi.org/10.1136/annrheumdis-2022-eular.3798

Zobrazit plný text záznamu

OP0061 TIGHT CONTROL IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TARGETED THERAPIES ACROSS THE COVID-19 PANDEMIC ERA

Autor: A. F. Luppino, G. Cincinelli, F. Ingegnoli, A. Orenti, E. G. Favalli, P. Boracchi, R. Caporali

Publikováno v: Annals of the Rheumatic Diseases. 81:42.2-42

BackgroundThe ongoing coronavirus disease 2019 (COVID-19) pandemic and subsequent waves still represent a healthcare issue. Their impact on the treat-to-target (T2T) strategy in rheumatoid arthritis (RA) patients has been seldom investigated. Difficu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0eaab588eee4045caf745ce238b3fc5b
https://doi.org/10.1136/annrheumdis-2022-eular.4825

Zobrazit plný text záznamu

POS0254 IMMUNE RESPONSE TO SARS-CoV-2 INFECTION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES: THE MAINSTREAM STUDY

Publikováno v: Annals of the Rheumatic Diseases. 81:367.2-368

BackgroundRheumatic musculoskeletal diseases (RMD) are pathological conditions characterized by an impaired immunological system that is determinant both in the pathogenesis and in the inadequate response to infections. The use of disease-modifying a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2a0fd64aeca6e4e2d12413eecd82a81
https://doi.org/10.1136/annrheumdis-2022-eular.1891

Zobrazit plný text záznamu

POS0943 EFFECT OF NERIDRONATE ON AXIAL SPONDYLOARTHRITIS WHEN bDMARDs ARE NOT AN OPTION: RESULTS FROM A RESTROSPECTIVE STUDY

Autor: C. Crotti, R. DI Taranto, E. G. Favalli, R. Caporali

Publikováno v: Annals of the Rheumatic Diseases. 81:775.2-776

BackgroundNonsteroidal anti-inflammatory drugs (NSAIDs) are recommended as first-line treatment of axial Spondyloarthritis (axSpA) and biological disease-modifying antirheumatic drugs (bDMARDs) are effective in the management of patients refractory t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::256fc2ccc89f5bf0177340d9fa466aa9
https://doi.org/10.1136/annrheumdis-2022-eular.3623

Zobrazit plný text záznamu

POS0607 IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS

Autor: L. Gossec, L. Bessette, R. Xavier, E. G. Favalli, A. Ostor, M. H. Buch

Publikováno v: Annals of the Rheumatic Diseases. 81:572.1-572

BackgroundTreat-to-target (T2T) is integral to international recommendations for managing patients with rheumatoid arthritis (RA),1,2 but its implementation in clinical practice is suboptimal.3 Understanding T2T barriers and facilitators may inform s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::36b24c77e58c9dbf867980179a388048
https://doi.org/10.1136/annrheumdis-2022-eular.2830

Zobrazit plný text záznamu

Pattern of use, economic burden and vial optimization of infliximab for rheumatoid arthritis in Italy

Autor: E G, Favalli, A, Marchesoni, G L, Colombo, L, Sinigaglia

Publikováno v: Clinical and experimental rheumatology. 26(1)

The aim of this study was to retrospectively examine the pattern of utilization in clinical practice and the costs of therapy of infliximab in the treatment of refractory rheumatoid arthritis (RA).Ninety-five RA patients (22 newly treated and 73 main

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5ee126301d5d38b957ff270aeb76711d
https://pubmed.ncbi.nlm.nih.gov/18328146

Zobrazit plný text záznamu

Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy

Autor: E G, Favalli, M, Varenna, L, Sinigaglia

Publikováno v: Clinical and experimental rheumatology. 23(2)

Agranulocytosis is a disorder characterized by a severe decrease in the number of granulocytes in blood, that frequently occurs as an adverse reaction to some drugs. By now, there are no reports in literature of agranulocytosis caused by tumur necros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4686562be59003e8b97f76bfc99082cc
https://pubmed.ncbi.nlm.nih.gov/15895899

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání